Does metabolic inflammation reduce HDL cholesterol and impair HDL function?

Metabolic inflammation, driven by chronic low-grade inflammatory states, fundamentally alters high-density lipoprotein (HDL) metabolism. This process both reduces circulating HDL levels and transforms the remaining particles from protective agents into dysfunctional, pro-inflammatory entities.

Quantitative reduction of HDL

• Suppressed Synthesis and Accelerated Clearance: Pro-inflammatory cytokines, specifically TNF-alpha and IL-6, directly suppress hepatic transcription of apolipoprotein A-I (apoA-I), the primary structural protein of HDL.
• Lipolytic and Lipid Transfer Activity: These cytokines upregulate endothelial lipase via NF-kB pathways, promoting HDL phospholipid hydrolysis and rapid catabolism. Concurrently, cholesteryl ester transfer protein (CETP) facilitates triglyceride enrichment of HDL, leading to swift degradation by hepatic lipase.
• Clinical Correlation: Systemic markers of low-grade inflammation, such as high-sensitivity C-reactive protein (hs-CRP), show a strong, direct inverse correlation with quantitative HDL cholesterol levels in cohort studies.

Functional and structural impairment

• Proteomic Remodeling: Inflammatory cytokines induce hepatic production of serum amyloid A (SAA), which accumulates on and remodels HDL, displacing apoA-I. Combined with reduced paraoxonase-1 (PON1) activity and myeloperoxidase (MPO)-mediated oxidation of apoA-I, HDL loses its antioxidant capacity and begins to actively propagate inflammatory cascades.
• Disrupted Reverse Cholesterol Transport: Structural alterations, particularly SAA enrichment and oxidized apoA-I, disrupt critical interactions with cellular membrane transporters, specifically ABCA1 and ABCG1. This severely compromises cholesterol efflux capacity, promoting macrophage foam cell formation and driving vascular inflammation.

Bottom line

• Metabolic inflammation quantitatively reduces HDL and qualitatively impairs its anti-inflammatory and reverse cholesterol transport functions, converting a cardioprotective particle into a dysfunctional, pro-inflammatory driver of vascular disease.